Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

IMRAN BAJWA

NPI
1871553222
CMS profile
311344
Location
INDIANA, PA

General Payments · PY2018–2024

$4,355.42

  • Reported across 315 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$651.87

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $551.92 37
Education $99.95 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $793.18 60
PY2019 $1,069.15 83
PY2020 $608.75 48
PY2021 $493.53 34
PY2022 $205.02 17
PY2023 $533.92 35
PY2024 $651.87 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $14.54 05/20/2024 Food and Beverage Undisputed 01/23/2026 1111522985 CMS
Amgen Inc. $13.83 11/21/2024 Food and Beverage Undisputed 01/23/2026 1111522989 CMS
AstraZeneca Pharmaceuticals LP $52.75 01/23/2024 Food and Beverage Undisputed 01/23/2026 1110542199 CMS
AstraZeneca Pharmaceuticals LP $13.90 02/19/2024 Food and Beverage Undisputed 01/23/2026 1110542557 CMS
AstraZeneca Pharmaceuticals LP $23.14 05/21/2024 Food and Beverage Undisputed 01/23/2026 1110539549 CMS
AstraZeneca Pharmaceuticals LP $20.81 08/20/2024 Food and Beverage Undisputed 01/23/2026 1110550374 CMS
AstraZeneca Pharmaceuticals LP $22.78 09/12/2024 Food and Beverage Undisputed 01/23/2026 1110544713 CMS
AstraZeneca Pharmaceuticals LP $17.41 10/10/2024 Food and Beverage Undisputed 01/23/2026 1110543765 CMS
Axsome Therapeutics, Inc. $19.30 01/29/2024 Food and Beverage Undisputed 01/23/2026 1148285787 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.52 08/20/2024 Food and Beverage Undisputed 01/23/2026 1118202403 CMS
GENZYME CORPORATION $17.57 02/06/2024 Food and Beverage Undisputed 01/23/2026 1139614010 CMS
GENZYME CORPORATION $13.39 04/30/2024 Food and Beverage Undisputed 01/23/2026 1139614214 CMS
GENZYME CORPORATION $14.50 05/28/2024 Food and Beverage Undisputed 01/23/2026 1139614234 CMS
GENZYME CORPORATION $14.20 08/26/2024 Food and Beverage Undisputed 01/23/2026 1139614270 CMS
GENZYME CORPORATION $14.79 10/01/2024 Food and Beverage Undisputed 01/23/2026 1139614284 CMS
GlaxoSmithKline, LLC. $5.35 01/25/2024 Food and Beverage Undisputed 01/23/2026 1116220856 CMS
GlaxoSmithKline, LLC. $16.00 02/13/2024 Food and Beverage Undisputed 01/23/2026 1116442995 CMS
GlaxoSmithKline, LLC. $10.19 02/28/2024 Food and Beverage Undisputed 01/23/2026 1115903446 CMS
GlaxoSmithKline, LLC. $7.20 03/19/2024 Food and Beverage Undisputed 01/23/2026 1116439401 CMS
GlaxoSmithKline, LLC. $10.00 04/29/2024 Food and Beverage Undisputed 01/23/2026 1116152249 CMS
GlaxoSmithKline, LLC. $8.45 05/06/2024 Food and Beverage Undisputed 01/23/2026 1116616392 CMS
GlaxoSmithKline, LLC. $5.79 05/29/2024 Food and Beverage Undisputed 01/23/2026 1116416245 CMS
GlaxoSmithKline, LLC. $12.40 07/22/2024 Food and Beverage Undisputed 01/23/2026 1116331873 CMS
GlaxoSmithKline, LLC. $20.77 08/12/2024 Food and Beverage Undisputed 01/23/2026 1116277814 CMS
GlaxoSmithKline, LLC. $8.33 09/10/2024 Food and Beverage Undisputed 01/23/2026 1116271548 CMS
GlaxoSmithKline, LLC. $5.08 09/19/2024 Food and Beverage Undisputed 01/23/2026 1116341966 CMS
GlaxoSmithKline, LLC. $1.95 10/11/2024 Food and Beverage Undisputed 01/23/2026 1116354092 CMS
GlaxoSmithKline, LLC. $10.00 10/21/2024 Food and Beverage Undisputed 01/23/2026 1116625644 CMS
GlaxoSmithKline, LLC. $14.64 10/24/2024 Food and Beverage Undisputed 01/23/2026 1116226936 CMS
GlaxoSmithKline, LLC. $12.65 11/18/2024 Food and Beverage Undisputed 01/23/2026 1116311577 CMS
GlaxoSmithKline, LLC. $8.00 12/16/2024 Food and Beverage Undisputed 01/23/2026 1116269771 CMS
Grifols USA, LLC $16.54 02/05/2024 Food and Beverage Undisputed 01/23/2026 1124723946 CMS
Insmed, Inc. $14.99 10/14/2024 Food and Beverage Undisputed 01/23/2026 1089557302 CMS
JAZZ PHARMACEUTICALS INC. $22.80 02/09/2024 Food and Beverage Undisputed 01/23/2026 1150236082 CMS
Regeneron Healthcare Solutions, Inc. $15.52 03/26/2024 Food and Beverage Undisputed 01/23/2026 1114003879 CMS
Regeneron Healthcare Solutions, Inc. $19.69 11/15/2024 Food and Beverage Undisputed 01/23/2026 1114003881 CMS
Regeneron Healthcare Solutions, Inc. $17.15 12/10/2024 Food and Beverage Undisputed 01/23/2026 1114003883 CMS
SANOFI-AVENTIS U.S. LLC $99.95 10/09/2024 Education Undisputed 01/23/2026 1139614300 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.